Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical relevance of hepatitis C virus genotypes.

Literature DB >> 9135513

Clinical relevance of hepatitis C virus genotypes.

P Simmonds¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1997 PMID： 9135513 PMCID： PMC1027074 DOI： 10.1136/gut.40.3.291

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

46 in total

1. Association between chronic hepatitis C infection and hepatocellular carcinoma.

Authors: G H Haydon; L M Jarvis; P Simmonds; P C Hayes
Journal: Lancet Date: 1995-04-08 Impact factor: 79.321

2. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors: G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal: Hepatology Date: 1994-01 Impact factor: 17.425

3. Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.

Authors: J C Booth; G R Foster; U Kumar; R Galassini; R D Goldin; J L Brown; H C Thomas
Journal: Gut Date: 1995-03 Impact factor: 23.059

4. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

Authors: C Féray; M Gigou; D Samuel; V Paradis; S Mishiro; G Maertens; M Reynés; H Okamoto; H Bismuth; C Bréchot
Journal: Gastroenterology Date: 1995-04 Impact factor: 22.682

5. Vaccination of chimpanzees against infection by the hepatitis C virus.

Authors: Q L Choo; G Kuo; R Ralston; A Weiner; D Chien; G Van Nest; J Han; K Berger; K Thudium; C Kuo
Journal: Proc Natl Acad Sci U S A Date: 1994-02-15 Impact factor: 11.205

6. Genotypes of hepatitis C virus in chronic liver disease in Taiwan.

Authors: C H Chen; J C Sheu; J T Wang; G T Huang; P M Yang; H S Lee; C Z Lee; D S Chen
Journal: J Med Virol Date: 1994-11 Impact factor: 2.327

7. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.

Authors: A Kasahara; N Hayashi; N Hiramatsu; M Oshita; H Hagiwara; K Katayama; M Kato; M Masuzawa; H Yoshihara; Y Kishida
Journal: Hepatology Date: 1995-02 Impact factor: 17.425

8. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease.

Authors: E Mita; N Hayashi; Y Kanazawa; H Hagiwara; K Ueda; A Kasahara; H Fusamoto; T Kamada
Journal: J Hepatol Date: 1994-09 Impact factor: 25.083

9. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.

Authors: F McOmish; S W Chan; B C Dow; J Gillon; W D Frame; R J Crawford; P L Yap; E A Follett; P Simmonds
Journal: Transfusion Date: 1993-01 Impact factor: 3.157

Review 10. Variability of hepatitis C virus.

Authors: P Simmonds
Journal: Hepatology Date: 1995-02 Impact factor: 17.425

11 in total

Review 1. The HCV and HIV coinfected patient: what have we learned about pathophysiology?

Authors: Andrew H Talal; P Wilfredo Canchis; Ira Jacobson
Journal: Curr Gastroenterol Rep Date: 2002-02

2. Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy.

Authors: Makoto Kadokura; Shinya Maekawa; Ryota Sueki; Mika Miura; Kazuki Komase; Hiroko Shindo; Fumitake Amemiya; Tomoyoshi Uetake; Taisuke Inoue; Minoru Sakamoto; Mina Nakagawa; Naoya Sakamoto; Mamoru Watanabe; Nobuyuki Enomoto
Journal: Hepatol Int Date: 2011-03-20 Impact factor: 6.047

3. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.

Authors: Ingrid Imhof; Peter Simmonds
Journal: J Virol Date: 2010-02-17 Impact factor: 5.103

4. Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy.

5. The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population.

Authors: Noor-Ul-Huda Ghori; Atif Shafique; Muhammad Qasim Hayat; Sadia Anjum
Journal: PLoS One Date: 2016-10-20 Impact factor: 3.240

6. Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity.

Authors: Ana Claudia Silva Braga; Bruno Moreira Carneiro; Mariana Nogueira Batista; Mônica Mayumi Akinaga; Cíntia Bittar; Paula Rahal
Journal: PLoS One Date: 2017-11-28 Impact factor: 3.240

7. Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia.

Authors: Kim Tien Ng; Yeat Mei Lee; Haider Abdulrazzaq Abed Al-Darraji; Xueshan Xia; Yutaka Takebe; Kok Gan Chan; Ling Lu; Sanjiv Mahadeva; Adeeba Kamarulzaman; Kok Keng Tee
Journal: Genome Announc Date: 2013-02-14

8. Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.

Authors: Isabelle Moreau; John Levis; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal: Virol J Date: 2008-07-09 Impact factor: 4.099

9. Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy.

Authors: Fatimah S Alhamlan; Mohammed N Al-Ahdal; Nisreen Z Khalaf; Ayman A Abdo; Faisal M Sanai; Hamad I Al-Ashgar; Mahmoud ElHefnawi; Amina Zaid; Ahmed A Al-Qahtani
Journal: J Transl Med Date: 2014-04-06 Impact factor: 5.531

10. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.

Authors: Shihyun You; Decherd D Stump; Andrea D Branch; Charles M Rice
Journal: J Virol Date: 2004-02 Impact factor: 5.103